HPV vaccine
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Evaluating Attitudes Toward HPV Vaccinations in Pharmacies
Conditions
Evaluating Attitudes Toward HPV Vaccinations in Pharmacies, Evaluating the Provision of HPV Vaccines in a Pharmacy
Trial Timeline
Jul 1, 2015 → Apr 1, 2018
NCT ID
NCT01960088About HPV vaccine
HPV vaccine is a pre-clinical stage product being developed by Merck for Evaluating Attitudes Toward HPV Vaccinations in Pharmacies. The current trial status is completed. This product is registered under clinical trial identifier NCT01960088. Target conditions include Evaluating Attitudes Toward HPV Vaccinations in Pharmacies, Evaluating the Provision of HPV Vaccines in a Pharmacy.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04171505 | Pre-clinical | UNKNOWN |
| NCT01960088 | Pre-clinical | Completed |